Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Awano

Showing results (61-70 of 152) with videos related to

Pageof 16
Sort By:
BMC Medical Genetics|March 31, 2010
Low incidence of limb-girdle muscular dystrophy type 2C revealed by a mutation study in Japanese patients clinically diagnosed with DMDYo Okizuka, Yasuhiro Takeshima, Kyoko Itoh, et al.
Scientific Reports|August 24, 2019
Incidence and Neonatal Risk factors of Short Stature and Growth Hormone treatment in Japanese Preterm Infants Born Small for Gestational AgeMasaaki Matsumoto, Nobuhiko Nagano, Hiroyuki Awano, et al.
BMC Pediatrics|May 6, 2024
An adolescent case of ASXL3-related disorder with delayed onset of feeding difficultyYuto Arai, Tohru Okanishi, Tetsuya Okazaki, et al.
Muscle & Nerve|March 21, 2024
Longitudinal data of serum creatine kinase levels and motor, pulmonary, and cardiac functions in 337 patients with Duchenne muscular dystrophyHiroyuki Awano, Yoshinori Nambu, Chieko Itoh, et al.
Genes|February 18, 2017
2'-O-Methyl RNA/Ethylene-Bridged Nucleic Acid Chimera Antisense Oligonucleotides to Induce Dystrophin Exon 45 SkippingTomoko Lee, Hiroyuki Awano, Mariko Yagi, et al.
Diagnostics (Basel, Switzerland)|March 28, 2025
Total Intramuscular Fat Fraction of Thigh Muscles as a Predictor of Nusinersen Efficacy in Pediatric SMA Type II and IIIKiiko Iketani, Hiroyuki Awano, Hiromi Hashimura, et al.
Nature Communications|May 11, 2011
Chemical treatment enhances skipping of a mutated exon in the dystrophin geneAtsushi Nishida, Naoyuki Kataoka, Yasuhiro Takeshima, et al.
International Journal of Neonatal Screening|November 29, 2021
DBS Screening for Glycogen Storage Disease Type 1a: Detection of c.648G>T Mutation in <i>G6PC</i> by Combination of Modified Competitive Oligonucleotide Priming-PCR and Melting Curve AnalysisEmma Tabe Eko Niba, Yogik Onky Silvana Wijaya, Hiroyuki Awano, et al.
Frontiers in Neurology|July 24, 2025
Serum titin/creatinine ratio as a biomarker for discriminating disease severity in Duchenne and Becker muscular dystrophiesYoshinori Nambu, Kayo Osawa, Taku Shirakawa, et al.
Nucleic Acid Therapeutics|October 5, 2011
Antisense oligonucleotide induced dystrophin exon 45 skipping at a low half-maximal effective concentration in a cell-free splicing systemRusdy Ghazali Malueka, Mariko Yagi, Hiroyuki Awano, et al.
Pageof 16

Showing results (61-70 of 152) with videos related to

Sort By:
Pageof 16
BMC Medical Genetics|March 31, 2010
Low incidence of limb-girdle muscular dystrophy type 2C revealed by a mutation study in Japanese patients clinically diagnosed with DMDYo Okizuka, Yasuhiro Takeshima, Kyoko Itoh, et al.
Scientific Reports|August 24, 2019
Incidence and Neonatal Risk factors of Short Stature and Growth Hormone treatment in Japanese Preterm Infants Born Small for Gestational AgeMasaaki Matsumoto, Nobuhiko Nagano, Hiroyuki Awano, et al.
BMC Pediatrics|May 6, 2024
An adolescent case of ASXL3-related disorder with delayed onset of feeding difficultyYuto Arai, Tohru Okanishi, Tetsuya Okazaki, et al.
Muscle & Nerve|March 21, 2024
Longitudinal data of serum creatine kinase levels and motor, pulmonary, and cardiac functions in 337 patients with Duchenne muscular dystrophyHiroyuki Awano, Yoshinori Nambu, Chieko Itoh, et al.
Genes|February 18, 2017
2'-O-Methyl RNA/Ethylene-Bridged Nucleic Acid Chimera Antisense Oligonucleotides to Induce Dystrophin Exon 45 SkippingTomoko Lee, Hiroyuki Awano, Mariko Yagi, et al.
Diagnostics (Basel, Switzerland)|March 28, 2025
Total Intramuscular Fat Fraction of Thigh Muscles as a Predictor of Nusinersen Efficacy in Pediatric SMA Type II and IIIKiiko Iketani, Hiroyuki Awano, Hiromi Hashimura, et al.
Nature Communications|May 11, 2011
Chemical treatment enhances skipping of a mutated exon in the dystrophin geneAtsushi Nishida, Naoyuki Kataoka, Yasuhiro Takeshima, et al.
International Journal of Neonatal Screening|November 29, 2021
DBS Screening for Glycogen Storage Disease Type 1a: Detection of c.648G>T Mutation in <i>G6PC</i> by Combination of Modified Competitive Oligonucleotide Priming-PCR and Melting Curve AnalysisEmma Tabe Eko Niba, Yogik Onky Silvana Wijaya, Hiroyuki Awano, et al.
Frontiers in Neurology|July 24, 2025
Serum titin/creatinine ratio as a biomarker for discriminating disease severity in Duchenne and Becker muscular dystrophiesYoshinori Nambu, Kayo Osawa, Taku Shirakawa, et al.
Nucleic Acid Therapeutics|October 5, 2011
Antisense oligonucleotide induced dystrophin exon 45 skipping at a low half-maximal effective concentration in a cell-free splicing systemRusdy Ghazali Malueka, Mariko Yagi, Hiroyuki Awano, et al.
Pageof 16